Answers are grounded in this paper and cite their sources.
This review highlights advances in molecular diagnostics for COVID-19, suggesting ongoing global efforts are crucial for future outbreaks.
Global efforts were made to develop sensitive, rapid, cost-effective, and noninvasive technologies to identify the pandemic virus, however variations in sensitivity/specificity and limited sample size validation hampered their utility in routine diagnostics. The COVID-19 pandemic has ended, but global efforts are still needed to combat the early infection of subsequent waves or similar disease waves.
No takes yet. Share an insight, caveat, or question.
Shukla et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: